CRISPR's gene editing therapy finds cure for blood cancer
STAT - 05-Dec-2020Early data from Vertex & CRISPR showed promising results to cure blood disorders
Adam Feuerstein
Senior Writer at stat news
Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. A veteran journalist, Adam was Senior Columnist at TheStreet, where he wrote about biotech and drug stocks.
Visit website: https://www.statnews.com/staff/adam-feuerstein/
See also
Details last updated 07-Dec-2020
Articles written by Adam Feuerstein
